⌕
Amneal Pharmaceuticals · AMRX · Nasdaq
Tenet 38 · Weak
Compare
$21.38−1.47%At closeTenet 38 · Weak
$21.38−0.32 (−1.47%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Amneal Pharmaceuticals (AMRX) Stock

Amneal Pharmaceuticals (AMRX) closed at $21.38 on Nov 13, 2026; its Tenet Score is 38 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

13 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$21.38
Nov 13, 2026
Market cap
$7.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
53.8×
price ÷ earnings
52-week range
11.39 – 22.07
low → high · as of close, Nov 13, 2026
Tenet Score
38/100
Weak · 313 Healthcare peers

Industry: Drugs

Amneal Pharmaceuticals Inc scores 38/100. Weak. Financial health is the soft spot, trading at 54× earnings versus 313 Healthcare peers.

Tenet Score · vs sector

n=313
38/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
33
Quality
54
Health
32
Growth
34

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityCHealthDGrowthDMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
14.0×
price to book value
P/S
2.3×
price to fiscal 2025 sales
ROE
99%
return on equity
Operating margin
13.1%
fiscal 2025, before interest and tax
Net margin
6.6%
of revenue kept
Current ratio
1.87
current assets to liabilities
Net debt / EBITDA
4.4×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segment…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 133 US ETFs · top wrappers by weightSee all ETFs holding AMRX →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Amneal Pharmaceuticals in?

Amneal Pharmaceuticals is in the Healthcare sector and the Drugs industry.

What is Amneal Pharmaceuticals' Tenet Score?

Amneal Pharmaceuticals' Tenet Score is 38 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.